biology-based companies.
Paragon is a global life science leader
that creates, builds and funds innovative

Featured Portfolio Companies

Emalex Biosciences is in late-stage development for a new class of drug for patients with Tourette syndrome and other neurological disorders. Learn More   → Harmony Biosciences (NASDAQ:HRMY) develops and commercializes innovative therapies for patients with rare neurological diseases. Learn More   → Evozyne leverages generative AI to design novel protein therapeutics for high unmet needs. Learn More   → Castle Creek Biosciences is a late-clinical stage regenerative medicine company focused on severe skin and connective tissue disorders. Learn More   → CiRC Biosciences develops regenerative medicines that restore function. Learn More   →

biology-based companies. builds and funds innovative Paragon is a global life science leader that creates,

Featured Portfolio Companies

Media

Featured Portfolio Companies

Emalex Biosciences is in late-stage development
for a new class of drug for patients with Tourette
syndrome and other neurological disorders.
Learn More   → Emalex Biosciences is in late-stage
development for a new class of drug
for patients with Tourette syndrome
and other neurological disorders.
Emalex Biosciences is in late-stage development for a
new class of drug for patients with Tourette syndrome
and other neurological disorders.
Learn More   →
Harmony Biosciences (NASDAQ:HRMY)
develops and commercializes
innovative therapies for patients
with rare neurological diseases.
Learn More   → Harmony Biosciences (NASDAQ:HRMY) develops
and commercializes innovative therapies for
patients with rare neurological diseases.
Learn More   → Harmony Biosciences (NASDAQ:HRMY) develops and commercializes innovative therapies for patients with rare neurological diseases.
Evozyne leverages generative AI to
design novel protein therapeutics
for high unmet needs.
Learn More   → Evozyne uses generative AI to design novel protein systems and develop treatments for diseases with
high unmet medical needs.
Learn More   → Evozyne leverages generative AI to design novel protein therapeutics for high unmet needs.
Castle Creek Biosciences is a late-clinical
stage regenerative medicine company
focused on severe skin and connective
tissue disorders.
Learn More   → Castle Creek Biosciences is a late-clinical stage
regenerative medicine company focused on
severe skin and connective tissue disorders.
Learn More   → Castle Creek Biosciences is a late-clinical stage regenerative medicine company focused on severe skin and connective tissue disorders.
CiRC Biosciences develops
regenerative medicines that restore
function.
Learn More   → CiRC Biosciences develops regenerative medicines
that restore function.
Learn More   → CiRC Biosciences develops regenerative medicines that restore function.

Media

Media